Publicacións en colaboración con investigadores/as de Universidade Federal de Goiás (2)

2022

  1. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

    RMD Open, Vol. 8, Núm. 2

2008

  1. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

    Arthritis and Rheumatism, Vol. 58, Núm. 10, pp. 2968-2980